Myeloproliferative Neoplasms

N Engl J Med. 2017 Jun 1;376(22):2168-2181. doi: 10.1056/NEJMra1406186.
No abstract available

Publication types

  • Review

MeSH terms

  • Age Factors
  • Antineoplastic Agents / therapeutic use
  • Bone Marrow Transplantation
  • Female
  • Gene Expression
  • Hematopoietic Stem Cells
  • Humans
  • Leukemia, Myeloid, Acute / etiology
  • Male
  • Mutation*
  • Myeloproliferative Disorders / complications
  • Myeloproliferative Disorders / diagnosis
  • Myeloproliferative Disorders / genetics*
  • Myeloproliferative Disorders / therapy
  • Phenotype
  • Polycythemia Vera / genetics
  • Polycythemia Vera / therapy
  • Primary Myelofibrosis / genetics
  • Primary Myelofibrosis / therapy
  • Sex Factors
  • Thrombocythemia, Essential / genetics
  • Thrombocythemia, Essential / therapy

Substances

  • Antineoplastic Agents